Swedish study of 100,000 women found higher rate of early detection, suggesting potential to support radiologists The use of artificial intelligence in breast cancer screening reduces the rate of a ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Prospective monitoring of prostate specific membrane antigen–positive biochemically recurrent prostate cancer (PSMA+ BCR): Preliminary data from 6-month PSMA follow-up.